GSK plc
GSK· NYSE
- Last sale
- Oct 1, 2026 · -2.10%
- Market cap
- —
- no share count on file
- Filings
- 1,060
Price
Oct 1, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | £32,667,000,000 | reported | |
| FY 2024 | 2024-12-31 | £31,376,000,000 | reported | |
| FY 2023 | 2023-12-31 | £30,328,000,000 | reported | |
| FY 2022 | 2022-12-31 | £29,324,000,000 | reported | |
| FY 2021 | 2021-12-31 | £24,696,000,000 revised | reported | |
| FY 2020 | 2020-12-31 | £24,354,000,000 revised | reported | |
| FY 2019 | 2019-12-31 | £33,754,000,000 | reported | |
| FY 2018 | 2018-12-31 | £30,821,000,000 | reported | |
| FY 2017 | 2017-12-31 | £30,186,000,000 | reported | |
| FY 2016 | 2016-12-31 | £27,889,000,000 | reported | |
| FY 2015 | 2015-12-31 | £23,923,000,000 | reported |
GSK plc · CIK 1131399 · Engraved from SEC EDGAR
